Your email has been successfully added to our mailing list.

×
0.0320247933884298 0.0320247933884298 -0.0826446280991734 -0.00836776859504127 -0.0661157024793387 -0.0702479338842975 -0.0916735537190082 -0.0754132231404957
Stock impact report

European Patent Office Grants New Patent Covering Enlivex’s Allocetra™ Immunotherapy Treatment

Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV) 
Company Research Source: GlobeNewswire
Nes-Ziona, Israel, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the European Patent Office granted a new patent (#EP 2 929 015 B1) covering ALLOCETRATM, the company’s immunotherapy product. This new patent adds intellectual property protection, including methods, uses and pharmaceutical compositions in the EU. ALLOCETRA™ is a novel immunotherapy based on a unique mechanism of action that targets life threatening diseases that are defined as “unmet medical needs” such as preventing or treating complications associated with bone marrow transplants (“BMT”) and/or hematopoietic stem cell transplants (“HSCT); organ dysfunction and acute multiple organ failure associated with sepsis and enablement of an effective treatment of solid tumors via immune checkpoint rebalancing. ABOUT ENLIVEX Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Im Show less Read more
Impact Snapshot
Event Time:
ENLV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ENLV alerts

from News Quantified
Opt-in for
ENLV alerts

from News Quantified